News New Vertex drugs could help 90% of cystic fibrosis patients Vertex soars after news that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time.
News AZ's asthma drug Fasenra approved in EU A further 3,400 children are eligible for treatment with Orkambi
News Promise of CF combinations lifts Vertex, reignites takeover ... Encouraging results from three pipeline combination therapies suggests Vertex could extend treatment to patients with more severe and difficult to treat cystic fibrosis.
News FDA chief nominee Gottlieb reveals industry links Scott Gottlieb, president Donald Trump’s nomination for FDA commissioner has revealed his close links with pharma.
News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Outlook bright for Vertex despite European delays But analysts excited by promise of next generation of medicines.
News Makary confirmed as Trump's FDA pick, with Weldon for CDC Martin Makary has been confirmed as Donald Trump's pick for FDA Commissioner, while Dave Weldon has been selected as his pick for CDC Director
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
